Fumonisin blunts nitric oxide-induced and nitroprusside-induced cardiomyocyte death

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 4, 2002, Pages 229-235

  Rabkin, Simon W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiomyocyte; Cell death; Ceramide; Fumonisin; Nitroprusside

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACYLTRANSFERASE; CERAMIDE; CERAMIDE DERIVATIVE; CERAMIDE SYNTHASE; FUMONISIN B1; GLUTATHIONE DERIVATIVE; HYDROGEN PEROXIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SPHINGANINE; SYNTHETASE; UNCLASSIFIED DRUG; DIBUTYRYL CYCLIC GMP; FUMONISIN; S NITROSOGLUTATHIONE;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; TIME; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; NEWBORN;

ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CELLS, CULTURED; CERAMIDES; DIBUTYRYL CYCLIC GMP; FUMONISINS; HYDROGEN PEROXIDE; MICE; MYOCYTES, CARDIAC; NITRIC OXIDE; NITROPRUSSIDE; S-NITROSOGLUTATHIONE;

EID: 0036433234     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00115-5     Document Type: Article

References (44)

1. B. Brune, A. von Knethen, K.B. Sandau, Nitric oxide and its role in apoptosis, Eur. J. Pharmacol. 351 (1998) 261-272.
2. M.P. Murphy, Nitric oxide and cell death, Biochim. Biophys. Acta 1411 (1999) 401-414.
3. H.T. Chung, H.O. Pae, B.M. Choi, T.R. Billiar, Y.M. Kim, Nitric oxide as a bioregulator of apoptosis, Biochem. Biophys. Res. Commun. 282 (2000) 1075-1079.
4. Y.M. Kim, C.A. Bombeck, T.R. Billiar, Nitric oxide as a bifunctional regulator of apoptosis, Circ. Res. 84 (1999) 253-256.
5. C. Stefanelli, C. Pignatti, B. Tantini, I. Stanic, F. Bonavita, C. Muscari, C. Guarnieri, C. Clo, C.M. Caldarera, Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes, Biochim. Biophys. Acta 1450 (1999) 406-413.
6. D.J. Pinsky, W. Aji, M. Szabolcs, E.S. Athan, Y. Liu, Y.M. Yang, R.P. Kline, K.E. Olson, P.J. Cannon, Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture, Am. J. Physiol. 277 (1999) H1189-H1199.
7. G. Taimor, B. Hofstaetter, H.M. Piper, Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia, Cardiovasc. Res. 45 (2000) 588-594.
8. T. Shimojo, M. Hiroe, S. Ishiyama, H. Ito, T. Nishikawa, F. Marumo, Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway, Exp. Cell Res. 247 (1999) 38-47.
9. D.J. Ing, J. Zang, V.J. Dzau, K.A. Webster, N.H. Bishopric, Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x, Circ. Res. 84 (1999) 21-33.
10. P. Andreka, J. Zang, C. Dougherty, T.I. Slepak, K.A. Webster, N.H. Bishopric, Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis, Circ. Res. 88 (2001) 305-312.
11. W. Song, X. Lu, Q. Feng, Tumor necrosis factor-α induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes, Cardiovasc. Res. 45 (2000) 595-602.
12. M.A. Arstall, D.B. Sawyer, R. Fukazawa, R.A. Kelly, Cytokine-mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation, Circ. Res. 85 (1999) 829-840.
13. R. Ullrich, M. Scherrer-Crosbie, K.D. Bloch, F. Ichinose, H. Nakajima, M.H. Picard, W.M. Zapol, Z.M. Quezado, Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice, Circulation 102 (2000) 1440-1446.
14. F. Sam, D.B. Sawyer, Z. Xie, D.L.F. Chang, S. Ngoy, D.A. Brenner, D.A. Siwik, K. Singh, C.S. Apstein, W.S. Colucci, Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction, Circ. Res. 89 (2001) 351-356.
15. A. deBelder, N. Robinson, P. Richardson, J. Martin, S. Moncada, Expression of inducible nitric oxide synthase in human heart failure, Circulation 95 (1997) 1672-1673.
16. S.W. Rabkin, J.Y. Kong, Nitroprusside induces cardiomyocyte death: Interaction with hydrogen peroxide, Am. J. Physiol. (Heart & Circulation) (2000) H3089-H3100.
17. Y.A. Hannun, C. Luberto, Ceramide in the eukaryotic stress response, Trends Cell Biol. 10 (2000) 73-80.
18. R.N. Kolesnick, M. Kronke, Regulation of ceramide production and apoptosis, Annu. Rev. Physiol. 60 (1998) 643-665.
19. Y. Takeda, M. Tashima, A. Takahashi, T. Uchiyama, T. Okazaki, Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3, J. Biol. Chem. 274 (1999) 10654-10660.
20. A. Huwiler, S. Dorsch, V.A. Briner, H. van den Bosch, J. Pfeilschifter, Nitric oxide stimulates chronic ceramide formation in glomerular endothelial cells, Biochem. Biophys. Res. Commun. 258 (1999) 60-65.
21. A. Huwiler, J. Pfeilschifter, H. van den Bosch, Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells, J. Biol. Chem. 274 (1999) 7190-7195.
22. C. De Nadai, P. Sestili, O. Cantoni, J.P. Lievremont, C. Sciorati, R. Barsacchi, S. Moncada, J. Meldolesi, E. Clementi, Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide, Proc. Natl. Acad. Sci. USA 97 (2000) 5480-5485.
23. A.H. Merrill Jr., D.D. Jones, An update of the enzymology and regulation of sphingomyelin metabolism, Biochim. Biophys. Acta 1044 (1990) 1-12.
24. A.H. Merrill Jr., E. Wang, T.R. Vales, E.R. Smith, J.J. Schroeder, D.S. Menaldino, C. Alexander, H.M. Crane, J. Xia, D.C. Liotta, F.I. Meredith, R.T. Riley, Fumonisin toxicity and sphingolipid biosynthesis, Adv. Exp. Med. Biol. 392 (1996) 297-306.
25. W.C. Gelderblom, C.M. Smuts, S. Abel, S.D. Snyman, M.E. Cawood, L. van der Westhuizen, S. Swanevelder, Effect of fumonisin B1 on protein and lipid synthesis in primary rat hepatocytes, Food Chem. Toxicol. 34 (1996) 361-369.
26. E.I.P. de Chaves, M. Bussiere, D.E. Vance, R.B. Campenot, J.E. Vance, Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons, J. Biol. Chem. 272 (1997) 3028-3035.
27. J.Y. Kong, S.W. Rabkin, Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes, Peptides 21 (2000) 1237-1247.
28. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol. Methods 5 (1983) 55-63.
29. S.W. Rabkin, J.Y. Kong, Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes, Eur. J. Pharmacol. 388 (2000) 209-217.
30. A.C. Loweth, N.G. Morgan, Methods for the study of NO-induced apoptosis in cultured cells, Methods Mol. Biol. 100 (1998) 311-320.
31. S.W. Rabkin, M. Ohmae, D.J. Klass, Antiarrhythmic e9ects of cyclic guanosine 3′:5′-monophosphate and sodium nitroprusside on barium chloride arrhythmias in rabbits, Arch. Int. Pharmacodyn. Ther. 257 (1982) 225-238.
32. J.R. Ciacci-Zanella, C. Jones, Fumonisin B1, a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumour necrosis factor pathway and caspase activation, Food Chem. Toxicol. 37 (1999) 703-712.
33. M. Koglin, K. Vehse, L. Budaeus, H. Scholz, S. Behrends, Nitric oxide activates the β 2 subunit of soluble guanylyl cyclase in the absence of a second subunit, J. Biol. Chem. 276 (2001) 30737-30743.
34. E.A. Martinova, A.H. Merrill Jr., Fumonisin B1 alters sphingolipid metabolism and immune function in BALB/c mice: Immunological responses to fumonisin B1, Mycopathologia 130 (1995) 163-170.
35. M.P. Sauviat, D. Laurent, F. Kohler, F. Pellegrin, Fumonisin, a toxin from the fungus Fusarium moniliforme sheld, blocks both the calcium current and the mechanical activity in frog atrial muscle, Toxicon 29 (1991) 1025-1031.
36. I. Meivar-Levy, A.H. Futerman, Up-regulation of neutral glycosphingolipid synthesis upon long term inhibition of ceramide synthesis by fumonisin B1, J. Biol. Chem. 274 (1999) 4607-4612.
37. G.W. Smith, P.D. Constable, C.W. Bacon, F.I. Meredith, W.M. Haschek, Cardiovascular effects of fumonisins in swine, Fund. Appl. Toxicol. 31 (1996) 169-172.
38. P. Rauhala, A. Khaldi, K.P. Mohanakumar, C.C. Chiueh, Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside, Free Radical Biol. Med. 24 (1998) 1065-1073.
39. J.D. Michenfelder, Cyanide release from sodium nitroprusside in the dog, Anesthesiology 46 (1977) 196-201.
40. D. Koesling, A. Friebe, Soluble guanylyl cyclase: structure and regulation, Rev. Physiol. Biochem. Pharmacol. 135 (1999) 41-65.
41. M.A. Moro, P. Fernandez-Tome, J.C. Leza, P. Lorenzo, I. Lizasoain, Neuronal death induced by SIN-1 in the presence of superoxide dismutase: Protection by cyclic GMP, Neuropharmacology 37 (1998) 1071-1079.
42. G. Forloni, E. Lucca, N. Angeretti, R. Chiesa, A. Vezzani, Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: Role of cyclic GMP, J. Neurochem. 68 (1999) 319-327.
43. J. Tejedo, J.C. Bernabe, R. Ramirez, F. Sobrino, F.J. Bedoya, NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells, FEBS Lett. 459 (1999) 238-243.
44. C. Ward, T.H. Wong, J. Murray, I. Rahman, C. Haslett, E.R. Chilvers, A.G. Rossi, Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism, Biochem. Pharmacol. 59 (2000) 305-314.